-
Integrated mental health care could improve treatment of older hospital inpatients with complex health needs Lancet Psychiatry (IF 30.8) Pub Date : 2024-08-10 Wolfgang Söllner
-
Proactive integrated consultation-liaison psychiatry and time spent in hospital by older medical inpatients in England (The HOME Study): a multicentre, parallel-group, randomised controlled trial Lancet Psychiatry (IF 30.8) Pub Date : 2024-08-10 Prof Michael Sharpe MD, Jane Walker PhD, Maike van Niekerk DPhil, Mark Toynbee DPhil, Nicholas Magill PhD, Prof Chris Frost MA, Prof Ian R White PhD, Prof Simon Walker MSc, Ana Duarte MSc, Colm Owens MBChB, Prof Chris Dickens PhD, Annabel Price PhD, HOME Study Team, Michael Sharpe, Jane Walker, Maike van Niekerk, Mark Toynbee, Nicholas Magill, Chris Frost, Ian R White, Simon Walker, Ana Duarte, Colm
Older people admitted to hospital in an emergency often have prolonged inpatient stays that worsen their outcomes, increase health-care costs, and reduce bed availability. Growing evidence suggests that the biopsychosocial complexity of their problems, which include cognitive impairment, depression, anxiety, multiple medical illnesses, and care needs resulting from functional dependency, prolongs hospital
-
Neuropsychiatric and work outcomes after COVID-19 hospitalisation Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-31 Tracy D Vannorsdall, Esther S Oh, Ann M Parker
-
Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-31 Maxime Taquet PhD, Zuzanna Skorniewska MSc, Thomas De Deyn MSc, Prof Adam Hampshire PhD, William R Trender MRes, Peter J Hellyer PhD, Prof James D Chalmers PhD, Prof Ling-Pei Ho PhD, Prof Alex Horsley PhD, Prof Michael Marks PhD, Krisnah Poinasamy LLM, Betty Raman DPhil, Olivia C Leavy PhD, Matthew Richardson PhD, Omer Elneima MRCP, Hamish J C McAuley MBBS, Aarti Shikotra PhD, Amisha Singapuri BSc
COVID-19 is known to be associated with increased risks of cognitive and psychiatric outcomes after the acute phase of disease. We aimed to assess whether these symptoms can emerge or persist more than 1 year after hospitalisation for COVID-19, to identify which early aspects of COVID-19 illness predict longer-term symptoms, and to establish how these symptoms relate to occupational functioning. The
-
WHO recommendations on psychological interventions for mental disorders Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-24 Kenneth Carswell, Pim Cuijpers, Brandon Gray, Dévora Kestel, Aiysha Malik, Inka Weissbecker, Mark van Ommeren
-
WHO treatment guideline for mental disorders Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-24 Falk Leichsenring, Allan Abbass, Peter Fonagy, Kenneth N Levy, Peter Lilliengren, Patrick Luyten, Nick Midgley, Barbara Milrod, Christiane Steinert
-
Friendships and peer relationships and self-harm ideation and behaviour among young people: a systematic review and narrative synthesis Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-15 Delfina Bilello PhD, Prof Ellen Townsend PhD, Prof Matthew R Broome PhD, Gregory Armstrong PhD, Stephanie Burnett Heyes PhD
Friendships and peer relationships have an important role in the experience of self-harm ideation and behaviour in young people, yet they typically remain overlooked. This systematic review and narrative synthesis explores the extant literature on this topic to identify important relationships between these constructs. We did a keyword search of peer-reviewed empirical articles relating to friendships
-
Prevention of in-hospital suicide in China Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-10 Lifeng Xiao, Qishuo Zhang
-
Pre-migration decision-making support for people affected by climate change Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-10 Muhammad Kamruzzaman Mozumder
-
Applying the EU regulatory framework for the clinical use of psychedelics. Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-04 Florence Butlen-Ducuing,Francisca Silva,Ivana Silva,Pavel Balabanov,Steffen Thirstrup
-
Polypharmacy for perinatal mood and anxiety disorders Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-02 Adele C Viguera
-
Concomitant use of antidepressants and benzodiazepines during pregnancy and associated risk of congenital malformations: a population-based cohort study in Taiwan Lancet Psychiatry (IF 30.8) Pub Date : 2024-07-02 Hui-Min Chuang PharmD, Lin-Chieh Meng MS, Chih-Wan Lin PhD, Wen-Wen Chen PharmD, Yi-Yung Chen MD, Prof Chi-Yung Shang MD PhD, Prof Liang-Kung Chen MD PhD, Prof Fei-Yuan Hsiao PhD
Despite the frequent co-administration of antidepressants and benzodiazepines, the association between such concomitant use during pregnancy and the risk of congenital malformations remains inadequately explored. This study aims to examine the association between concomitant use of antidepressants and benzodiazepines during the first trimester and organ-specific congenital malformations. We conducted
-
Promoting academic forensic psychiatry in low-income and middle-income countries. Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-27 Yasin Hasan Balcioglu
-
Forensic mental health: envisioning a more empirical future. Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-27 John Tully,Jonathan Hafferty,Daniel Whiting,Kimberlie Dean,Seena Fazel
Forensic mental health services provide crucial interventions for society. Such services provide care for people with mental disorders who commit violent and other serious crimes, and they have a key role in the protection of the public. To achieve these goals, these services are necessarily expensive, but they have been criticised for a high-cost, low-volume approach, for lacking consistent standards
-
-
The persistent value of lesions in psychiatric neurosurgery. Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-18 Hael Abdulrazeq,Alexander P Philips,Rahul Sastry,Peter M Lauro,Nicole C R McLaughlin,Wael F Asaad
Neurosurgery for intractable psychiatric conditions has seen a resurgence with the increasing use of deep brain stimulation (DBS). Although DBS promises reversible neuromodulation and has become more popular than older lesioning methods, lesioning might still be preferred in specific cases. Here, we review the evidence for DBS and lesions in the treatment of intractable neuropsychiatric conditions
-
-
Suicide and bipolar disorder: opportunities to change the agenda. Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-14 Tania Gergel,Frances Adiukwu,Melvin McInnis
-
Decriminalisation of suicide attempt in Ghana: a call to action. Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-14 Winifred Asare-Doku,Gordon M Donnir,Priscilla Osei-Bonsu,Joseph Osafo
-
Ignacio Labayen de Inza—helping people face the dark world of chemsex Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Tony Kirby
-
-
-
Cognitive dysfunction in functional seizures: a neurologist's perspective Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Ingrid Hoeritzauer
-
Treatment paradigms for treatment-resistant schizophrenia Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Carol Lim, Abigail L Donovan
-
Using mental health policy to combat terrorism in Nigeria Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Taiwo Opekitan Afe, Olawale Ogunsemi, Blessing Afe
-
De-implementation to reduce coercive practices in mental health care Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Sophie Sergerie-Richard, Marie-Hélène Goulet, Alexandre Dumais, Catherine Hinse, Guillaume Fontaine
-
Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Nurul Husna Salahuddin MSc, Alexandra Schütz MSc, Gabi Pitschel-Walz PhD, Susanna Franziska Mayer MSc, Anna Chaimani PhD, Spyridon Siafis MD, Prof Josef Priller PhD, Prof Stefan Leucht MD, Irene Bighelli PhD
Many patients with schizophrenia have symptoms that do not respond to antipsychotics. This condition is called treatment-resistant schizophrenia and has not received specific attention as opposed to general schizophrenia. Psychological and psychosocial interventions as an add-on treatment to pharmacotherapy could be useful, but their role and comparative efficacy to each other and to standard care
-
Cognitive performance in functional seizures compared with epilepsy and healthy controls: a systematic review and meta analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Ryan Van Patten PhD, Tara A Austin PhD, Erica Cotton PsyD, Lawrence Chan PsyD, John A Bellone PhD, Kristen Mordecai PhD, Hamada Altalib MD, Stephen Correia PhD, Elizabeth W Twamley PhD, Richard N Jones ScD, Kelsey Sawyer MS, W Curt LaFrance Jr MD MPH
Cognition is a core component of functional seizures, but the literature on cognition in this disorder has been heterogeneous, with no clear unifying profile emerging from individual studies. The aim of this study was to do a systematic review and meta-analysis of cognitive performance in adults with functional seizures compared with epilepsy (including left temporal lobe epilepsy) and compared with
-
Stepped care approaches for people with personality disorder Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-12 Gary Lamph, Mike Crawford
-
Involving and supporting families, friends, and carers during a mental health crisis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-11 Dorit Braun, Karen Lascelles
-
Integration of guidance following mass trauma Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-06 David Forbes, Keren Doenyas-Barak, Neil Greenberg, Integration Guidance Following Mass Trauma Working Group
-
Discontinuation symptoms of antidepressants Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-05 Glyn Lewis, Gemma Lewis
-
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-05 Jonathan Henssler MD, Yannick Schmidt MD, Urszula Schmidt MD, Guido Schwarzer PhD, Prof Tom Bschor MD, Prof Christopher Baethge MD
Antidepressant discontinuation symptoms are becoming an increasingly important part of clinical practice, but the incidence of antidepressant discontinuation symptoms has not been quantified. An estimate of antidepressant discontinuation symptoms incidence could inform patients and clinicians in the discontinuation of treatment, and provide useful information to researchers in antidepressant treatments
-
Promoting LGBTQIA+ rights in India Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-03 Aditi Bakshi, Sheikh Shoib, Sahifa Anjum, Jagadeeswari Vardha, Abdul Khayum, Ilham Zaidi
-
Preventing suicide in people who experience incarceration Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-29 Stuart A Kinner, Maha Aon, Rohan Borschmann
-
Worldwide incidence of suicides in prison: a systematic review with meta-regression analyses Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-29 Prof Adrian P Mundt PhD, Pablo A Cifuentes-Gramajo PhD, Gergő Baranyi PhD, Prof Seena Fazel PhD
Suicide is a leading cause of death during imprisonment. This systematic review aimed to synthesise available evidence of prison suicide incidence worldwide. We systematically searched the scientific literature, data repositories, and prison system reports, supplemented by correspondence with prison administrations. We included reports on people living in prison but excluded studies in preselected
-
Post-Roe v Wade psychiatry: legal, clinical, and ethical challenges in psychiatry under abortion bans. Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-22 Nina V Kraguljac,Debra P Bruns,Paul S Appelbaum,Erika Botello,Victoria L King,Natalie Remiszewski,Alik S Widge,Jonathan E Alpert,Linda L Carpenter,Adrienne Grzenda,John H Krystal,William M McDonald,Charles B Nemeroff
In recent history, the world has witnessed a trend towards liberalization of abortion laws driven by an increasing understanding of the negative personal and public health consequences of criminalizing abortion. By contrast, several countries have recently implemented restrictive reproductive laws, joining the 112 countries where access to abortion care is banned completely or with narrow exceptions
-
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-22 Robert A McCutcheon MRCPsych PhD, Lilian A E Weber PhD, Matthew M Nour MRCPsych PhD, Prof Stephanie J Cragg DPhil, Prof Philip M McGuire FRCPsych PhD
Dopaminergic receptor antagonism is a crucial component of all licensed treatments for psychosis, and dopamine dysfunction has been central to pathophysiological models of psychotic symptoms. Some clinical trials, however, indicate that drugs that act through muscarinic receptor agonism can also be effective in treating psychosis, potentially implicating muscarinic abnormalities in the pathophysiology
-
10 years of The Lancet Psychiatry Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 The Lancet Psychiatry
-
Naming and coming to terms with bipolar hypersexuality Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Anne Chataigné
-
-
Perspectives on adolescent mental health after the COVID-19 pandemic Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Christian Hakulinen, Kaisla Komulainen
-
Breaking boxes: announcing the Lancet Psychiatry Commission on Lived Experience in Mental Health Research Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Laura Fischer, Sullivan Holderbach, Hanna Kienzler, Dylan Reddish, Lou Robbin, Angela Sweeney
-
Omission of mental health lived-experience research in implementation research commission Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Victoria J Palmer, Michelle Banfield
-
Opioid agonist treatment in Iran after an opium poppy ban in Afghanistan Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Bijan Pirnia
-
Suicide among medical residents in Iran Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Bijan Pirnia
-
Mental health after the COVID-19 pandemic among Finnish youth: a repeated, cross-sectional, population-based study Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Olli Kiviruusu PhD, Klaus Ranta MD PhD, Maija Lindgren PhD, Henna Haravuori MD PhD, Yasmina Silén MD PhD, Sebastian Therman PhD, Jukka Lehtonen PhD, Laura Sares-Jäske PhD, Terhi Aalto-Setälä MD PhD, Prof Mauri Marttunen MD PhD, Prof Jaana Suvisaari MD PhD
High levels of mental health problems among young people were reported during the COVID-19 pandemic, but studies of the post-pandemic period are scarce. We assessed mental health problems among Finnish youth before, during, and after the COVID-19 pandemic using nationwide population-based samples. Our aim was to examine in which direction the heightened levels of adolescent mental health problems have
-
Hypersexuality in bipolar disorder: an overlooked symptom Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Clare Dolman, Louise Howard, Guy M Goodwin, Allan Young, Ian R Jones, Veerle Bergink, Thomas Richardson, Arianna Di Florio
-
School-based interventions to support mental health in adolescents: what works BESST? Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-14 Deborah M Caldwell
-
Clinical effectiveness and cost-effectiveness of a brief accessible cognitive behavioural therapy programme for stress in school-aged adolescents (BESST): a cluster randomised controlled trial in the UK Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-14 June Brown DClin Psy, Kirsty James MSc, Stephen Lisk PhD, James Shearer PhD, Prof Sarah Byford PhD, Prof Paul Stallard PhD, Prof Jessica Deighton PhD, David Saunders PhD, Jynna Yarrum MSc, Prof Peter Fonagy PhD, Timothy Weaver PhD, Irene Sclare DClin Psy, Crispin Day DClin Psy, Claire Evans MSc, Prof Ben Carter PhD
Depression and anxiety are increasingly prevalent in adolescents. The Brief Educational Workshops in Secondary Schools Trial investigated the effectiveness of a brief accessible stress workshop programme for 16–18-year-olds. We aimed to investigate the clinical effectiveness and cost-effectiveness of the DISCOVER cognitive behavioural therapy (CBT) workshop on symptoms of depression in 16–18-year-olds
-
Suicide prevention: reflections on progress over the past decade Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-13 Prof Keith Hawton FMedSci, Prof Jane Pirkis PhD
Interest in preventing suicides has increased greatly in recent years. In this Personal View, we consider the general global developments related to suicide prevention that have occurred in the decade since was first published in 2014. We then review specific advances during this period, first, in relation to public health initiatives, and second, with regard to clinical developments. Finally, we examine
-
Predictive coding and phenomenological approaches of delusions: convergence and differences – Authors' reply Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Jessica Niamh Harding, Noham Wolpe, Stefan Peter Brugger, Victor Navarro, Christoph Teufel, Paul Charles Fletcher
-
Target trial emulation in psychiatry: a call for more rigorous observational analyses Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Alejandro G Szmulewicz
-
Predictive coding and phenomenological approaches of delusions: convergence and differences Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Jasper Feyaerts, Rosa Ritunnano, Gert Jensen, Louis Sass
-
Nurse prescribers as key players in shared decision making in psychiatry Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-30 Junqiang Zhao, Yumi Aoki, Yaara Zisman-Ilani
-
Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine? Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-30 Jack B Fanshawe, Belinda R Lennox
-
Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case–control study in Finland Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-30 Jose M Rubio MD, John M Kane MD, Antti Tanskanen PhD, Jari Tiihonen MD, Heidi Taipale PhD
Agranulocytosis is a life-threatening side-effect of clozapine, the only approved drug for treatment-resistant schizophrenia. The long-term profile of this complication has not yet been well established. Here we aim to describe the risk of clozapine-induced agranulocytosis over the long term. We used the entire population of Finland to identify people diagnosed with schizophrenia or schizoaffective
-
Engaging in healthy life activities is inherently valuable Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-23 Helene Speyer, Jim van Os
-
A transdiagnostic group exercise intervention for mental health outpatients in Germany (ImPuls): results of a pragmatic, multisite, block-randomised, phase 3 controlled trial Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-23 Sebastian Wolf PhD, Britta Seiffer MSc, Johanna-Marie Zeibig PhD, Anna Katharina Frei MSc, Thomas Studnitz MSc, Jana Welkerling MSc, Edith Meinzinger BSc, Leonie Louisa Bauer MSc, Julia Baur PhD, Stephanie Rosenstiel PhD, David Victor Fiedler MSc, Florian Helmhold MSc, Andreas Ray PhD, Eva Herzog MSc, Keisuke Takano PhD, Tristan Nakagawa PhD, Mia Maria Günak MSc, Saskia Kropp MSc, Stefan Peters PhD
Globally, mental health conditions pose a substantial burden of disease. Despite the availability of evidence-based pharmacological and psychological treatments, the symptoms of a substantial subgroup of patients do not respond to these interventions, and only a minority of patients have access to them. This study aimed to assess the efficacy of ImPuls, a 6-month transdiagnostic group exercise intervention
-